Two-thirds of executives plan to leave their current company, signaling a need to rethink succession planning and build stronger leadership pipelines. NEW YORK CITY, NY / ACCESS Newswire / September 29, 2025 / LHH, the integrated professional talent solutions provider and global business unit of the Adecco Group, today releases its report reviewing the current […]
Two-thirds of executives plan to leave their current company, signaling a need to rethink succession planning and build stronger leadership pipelines. NEW YORK CITY, NY / ACCESS Newswire / September 29, 2025 / LHH, the integrated professional talent solutions provider and global business unit of the Adecco Group, today releases its report reviewing the current
Ridgefield, Connecticut, U.S. Boehringer Ingelheim today announced the launch of its new direct-to-consumer platform, “Boehringer Ingelheim Access.” The platform will offer a convenient way for patients in the U.S. to order and receive home delivery of select Boehringer medicines at reduced prices, increasing access to important therapies. SPIRIVA(R) RESPIMAT(R) (tiotropium bromide) Inhalation Spray 2.5 mcg
Vascarta Inc., a clinical-stage biopharmaceutical company advancing innovative treatments for pain and inflammation, announced today the successful completion of its phase 1 clinical trial evaluating VAS-101 (Vasceptor®) for the treatment of osteoarthritis (OA). The study was conducted at Clinical Research Australia in Perth under the direction of Principal Investigator Dr. Adrian Lopresti. Publication and/or presentation
Community-driven development adjacent to Pittsburgh Yards® will includeaffordable commercial, light industrial, arts, greenspaces and residential uses tobenefit the Pittsburgh community along Southside Trail Atlanta Beltline has issued a Request for Proposals (RFP) to transform 13.7 acres at 356 University Avenue to create a mixed use and mixed income development in the historic Pittsburgh neighborhood along
— Awiqli® (insulin icodec) injection, if approved, has the potential to be the first once-weekly basal insulin treatment available in the US for adult type 2 diabetes — In adults with type 2 diabetes, the ONWARDS clinical trial program evaluated the change in A1C from baseline withAwiqli® compared to daily basal insulin1-5 — Resubmission reflects
The following issues have been halted by CIRO Company: V Ten Capital Corp. TSX-Venture Symbol: VTEN.P All Issues: Yes Reason:Pending News Halt Time (ET): 7:53AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly
Boehringer Ingelheim launches new direct-to-consumer platform to expand patient access to important treatments GlobeNewswire September 29, 2025 Ridgefield, Connecticut, U.S. Boehringer Ingelheim today announced the launch of its new direct-to-consumer platform, “Boehringer Ingelheim Access.” The platform will offer a convenient way for patients in the U.S. to order and receive home delivery of select Boehringer
(NYSE MKT:SYNX), Netanya, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, today announced that it has received a new purchase order valued at approximately $100,000 from a leading military unit for its tactical headset systems and related
(NasdaqGM:CADL), CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate hypofractionated radiotherapy with curative intent, independent of the specific modality of radiation therapy used NEEDHAM, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a